EC Number   |
Activating Compound |
Reference |
|---|
   3.4.24.35 | 2,3,7,8-tetrachlorodibenzo-p-dioxin |
both MMP-9 mRNA expression and enzymatic activity are gradually increased with the concentration increase of 2,3,7,8-tetrachlorodibenzo-p-dioxin in media and these changes can be reversed by resveratrol treatment in a dose-dependent manner, c-Jun mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced MMP-9 expression and activity |
696967 |
| 3.4.24.35 | 4-amino phenylmercuric acetate |
pro-MMP-9 is activated with 1 mM 4-amino phenylmercuric acetate in assay buffer at 37°C for 1.5 h |
708820 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
- |
710587 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
1 mM |
708188 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
1 mM 4-aminophenylmercuric acetate-mediated activation of MMP-9 provokes autocatalytic cleavage of recombinant MMP-9 |
709948 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
activation of pro-MMP-9 constructs at pH 7.0 |
718355 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
after treatment with 4-aminophenylmercuric acetate, affinity-purified W-256 cell gelatinase is converted to a final processed form of 66000 Da |
709920 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
APMA activation of MMP-9 affects tissue inhibitor of metalloproteinase-1 binding to the enzyme resulting in the loss of natural enzyme inhibition |
707123 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
artificial activation of the inactive zymogen |
718385 |
| 3.4.24.35 | 4-aminophenylmercuric acetate |
proteolytically activates the enzyme |
683429 |
